In drie stappen
het juiste contact
70 betrokken LIOF’ers helpen jouw bedrijf groeien met advies, een waardevol netwerk en financiering op weg naar een slimmer, duurzamer en gezonder Limburg.
How to enter the U.S. medical market
LIOF and Brightlands Maastricht Health Campus are organizing an exclusive two-day workshop to prepare medical companies for the U.S. market. The U.S. market is attractive to European manufacturers of medical products due to its extensive healthcare expenditure and strong demand for advanced products and technologies. Due the challenges on the European MDR-regulations, more and more medical companies consider to go to the U.S. market parallel to or even prior to the EU market.
In this two day workshop, American experts from RQR Capital address key topics that characterize the U.S. market and that are crucial to prepare for. They come to the Netherlands especially for this workshop!
Topics
> staan de topics in onderstaande tekst? Of doen we het als volgt:
- FDA (Food and Drug Administration) Approval: Any company that manufactures, repackages or relabels goods for export to the United States must be FDA certified
- Requirement of clinical data
- Strategy to enter U.S. market
- Knowledge of U.S. healthcare and reimbursement system.
For European manufacturers of medical products it’s crucial to thoroughly prepare for the U.S. market due to the FDA's strict regulations, which require extensive documentation and clinical data. Good preparation is crucial to manage the high costs and complex procedures of approval and market entry. In addition, companies must develop a strategy to compete with strong local players and adapt to the unique dynamics of the U.S. healthcare and reimbursement system. Without this preparation, they run the risk of delays, additional costs, and limited market penetration
U.S. market is attractive
With the U.S. being the largest healthcare market in the world, successful access offers the opportunity for significant revenue growth. Additionally, FDA approval can serve as a globally recognized standard for quality and safety, strengthening the reputation of products and facilitating access to other international markets.
Program and location
The workshop will be held at the Brightlands Maastricht Health Campus in Maastricht.
> hier komt het programma
Who can participate?
> hier doelgroep uitlichten
Costs
The costs for participating this workshop are dependent on the number of participants per company:
- 1 participant: € 300,- p.p.
- 2 participants: € 275,- p.p.
- 3 participants: € 250,- p.p.
- > 3 participants: € 225,- p.p.
These costs are including taxes and including ticketing service fee.
> Betaling en procedure verder uitlichten
Registration
You can register through the button below.
RegisterAbout the speakers
...
About RQR Capital
The workshop is led by RQR Capital, an advisory firm specialized in the commercial viability for the U.S. market of early-stage health innovations. RQR Capital has offices in the U.S. and in the Netherlands. In this two day workshop, the experts from RQR Capital address key topics that characterize the U.S. market and that are crucial to prepare for. For more information, go to www.rqrcapital.com.
More information?
If you need more information about this event? Please do not hesitate to contact us!
Opslaan op je telefoon?
Scan de QR code.
